Ataibeckley Inc (ATAI) - News Archive

Atai Life Sciences: Navigating Financial Challenges Amid Promising Clinical Trials for Treatment-Resistant DepressionAtai Life Sciences, a leading innovator in the biotechnology and mental health sectors, has recently a...

In a significant move to bolster its operations, Atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company dedicated to revolutionizing mental health disorder treatments, announced the successful clo...

Atai Life Sciences: Pioneering the Future of Mental Health TreatmentIn a momentous move poised to redefine the landscape of mental health treatment, Atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical...

In recent years, mental health disorders have emerged as one of the most significant and challenging global healthcare concerns. Major Depressive Disorder (MDD) affects millions of individuals worldwide, causing debilit...

atai Life Sciences, a renowned clinical-stage biopharmaceutical company focused on revolutionizing the treatment of mental health disorders, has successfully administered the first dose of BPL-003 (intranasal 5-MeO-DMT)...

Phase 1 Study of BPL-003 Shows Promise in Treating Mental Health Disorders is pleased to present the findings of the Phase 1 study of BPL-003, a novel synthetic intranasal benzoate salt formulation of 5-MeO-DMT, conduct...

In a recent ground-breaking development for the treatment of treatment-resistant depression (TRD), atai Life Sciences, a major player in psychedelic therapeutics sector, announced preliminary results from a phase 2a ope...

The collaboration between atai Life Sciences and Beckley Psytech is aimed at accelerating the clinical development of short-duration psychedelics. These substances have shown promise in rapidly alleviating symptoms of v...

atai Life Sciences, a renowned clinical-stage biopharmaceutical company dedicated to revolutionizing mental health disorder treatments, has recently disclosed encouraging findings from their Phase 1 study involving EMP-...